BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. glucose metabolic process, Lung cancer, Leukocyte, Early pregnancy factor, SLC12A1)
Bookmark Forward

QuickView for eclampsia (phenotype)


Genetic Markers

Most Correlated Genes

Most Correlated SNPs

  1. STOX1
  2. PEE2
  3. PEE3
  4. PEE1
  1. No SNPs found
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. positive regulation of otic vesicle morphogenesis
  2. Storkhead-box protein, winged-helix domain
  3. regulation of mitochondrial DNA metabolic process
  4. positive regulation of cell cycle G2/M phase transition
  5. regulation of transcription from RNA polymerase II promoter in response to hypoxia
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Mouse Phenotypes - Urogenital disorders
  2. Placental gene expression in severe preeclampsia
  3. OMIM - Vascular disease
  4. Placental tissue from women with early and late onset pre-eclampsia
  5. Severe preeclampsia-related changes in gene expression
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Higher Circulating Lymphocytes and the Incidence of Pre-eclampsia and Eclampsia.
  2. Pre-eclampsia.
  3. Atypical eclampsia in a normotensive patient with altered mental status and severely elevated transa…
  4. Feto-maternal indicators of cardiac dysfunction as a justification for the cardiac origins for pre-e…
  5. Causal relationship between iron status and preeclampsia-eclampsia: a Mendelian randomization analys…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Improved Characterisation of Eclampsia
  2. Blood Pressure in Adolescents With PReclampsia and Eclampsia.
  3. CA-125 and Severity of Pre-Eclampsia
  4. The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
  5. Factors Predicting Transformation of Non Severe Pre-eclampsia Into Pre-eclampsia With Severe Feature…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.